These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 9107077)

  • 141. Diagnoses in patients with severe pancytopenia suspected of having aplastic anemia.
    Keisu M; Ost A
    Eur J Haematol; 1990 Jul; 45(1):11-4. PubMed ID: 2379559
    [TBL] [Abstract][Full Text] [Related]  

  • 142. [Studies on the subpopulations of peripheral lymphocytes of the patients with idiopathic aplastic anemia (author's transl)].
    Nakata Y; Arimori S; Tada S; Kobashi H
    Rinsho Ketsueki; 1973 Nov; 14(11):1075-9. PubMed ID: 4544620
    [No Abstract]   [Full Text] [Related]  

  • 143. GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia.
    Ganapathi KA; Townsley DM; Hsu AP; Arthur DC; Zerbe CS; Cuellar-Rodriguez J; Hickstein DD; Rosenzweig SD; Braylan RC; Young NS; Holland SM; Calvo KR
    Blood; 2015 Jan; 125(1):56-70. PubMed ID: 25359990
    [TBL] [Abstract][Full Text] [Related]  

  • 144. Epidemiologic and HLA antigen profile in patients with aplastic anemia.
    Taj M; Shamsi TS; Ansari SH; Farzana T; Nazi A; Nadeem M; Qureshi RN; Sheikh K; Kazmi JH
    J Coll Physicians Surg Pak; 2014 Aug; 24(8):549-52. PubMed ID: 25149831
    [TBL] [Abstract][Full Text] [Related]  

  • 145. [Long term evolution in Blackfan-Diamond hypoplastic anemia (author's transl)].
    García-Miguel P; Muñoz Villa A; Hurtado Ruano T; González Martín MC; Fernández Rodríguez P
    An Esp Pediatr; 1976; 9(4):384-90. PubMed ID: 984600
    [TBL] [Abstract][Full Text] [Related]  

  • 146. Dysmegakaryopoiesis and Transient Mild Increase in Bone Marrow Blasts in Patients With Aplastic Anemia Treated With Eltrombopag May Be Signs of Hematologic Improvement and Not Portend Clonal Evolution.
    Matsuda A; Imada K; Obara N; Iida H; Yamazaki H; Tomiyama Y; Miyamura K; Sasaki O; Maeda T; Ohta K; Usuki K; Tokumine Y; Imajo K; Okamoto Y; Murakami M; Nakao S
    Am J Clin Pathol; 2022 Nov; 158(5):604-615. PubMed ID: 36018052
    [TBL] [Abstract][Full Text] [Related]  

  • 147. The bone marrow in aplastic anaemia: diagnostic and prognostic features.
    Frisch B; Lewis SM
    J Clin Pathol; 1974 Mar; 27(3):231-41. PubMed ID: 4832303
    [TBL] [Abstract][Full Text] [Related]  

  • 148. Evolution and prognosis of aplastic anemia.
    Ruvidić R; Bosković D; Jovanović V; Pavlović-Kentera V; Mijović A
    Acta Med Iugosl; 1985; 39(1):33-9. PubMed ID: 3993429
    [No Abstract]   [Full Text] [Related]  

  • 149. [Deciphering Hypoplastic Myelodysplastic Syndrome and Aplastic Anemia via In-Depth Analysis of Lymphocyte Subsets].
    Wu HF; Wang SC; Huang JB; Huo JL; Shao YQ; Ren X; Li XX; Wang M; Nie N; Zhang J; Jin P; Ge ML; Zheng YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Auguest; 31(4):1125-1132. PubMed ID: 37551487
    [TBL] [Abstract][Full Text] [Related]  

  • 150. Correlation between dysplastic lineage and type of cytopenia in myelodysplastic syndromes patients with refractory anemia according to the FAB classification.
    Matsuda A; Jinnai I; Iwanaga M; Okamura D; Ishikawa M; Maeda T; Hata T; Kawai N; Miyazaki Y; Bessho M; Tomonaga M
    Am J Clin Pathol; 2013 Aug; 140(2):253-7. PubMed ID: 23897263
    [TBL] [Abstract][Full Text] [Related]  

  • 151. [Evaluation of marrow neutrophilic reserve in normal subjects and aplastic anemia patients].
    Ko WS; Chen LM; Hwang SH; Hwang WS
    Zhonghua Yi Xue Za Zhi (Taipei); 1992 Mar; 49(3):189-93. PubMed ID: 1316211
    [TBL] [Abstract][Full Text] [Related]  

  • 152. [Diagnosis, course and outcome of myelodysplasias].
    Riauzova LIu; Soloveĭ DIa; Iavorkovskiĭ LI; Iavorkovskiĭ LL; Grinberg LIa
    Gematol Transfuziol; 1988 Aug; 33(8):19-23. PubMed ID: 3192050
    [No Abstract]   [Full Text] [Related]  

  • 153. [The comparative characteristics of the clinico-hematological indices in patients with different forms of myelodysplasias].
    Pesotskaia LA
    Lik Sprava; 1997; (2):59-62. PubMed ID: 9333486
    [TBL] [Abstract][Full Text] [Related]  

  • 154. [Characteristics of hematopoiesis in hypoplastic anemia].
    Faĭnshteĭn FE; Turbina NS; Shishina RN; Rozanova NS
    Klin Med (Mosk); 1975 Oct; 53(10):111-5. PubMed ID: 1230562
    [No Abstract]   [Full Text] [Related]  

  • 155. The significance of lymphocytosis in congenital hypoplastic anemia.
    Miale TD; Bloom GE
    J Pediatr; 1975 Oct; 87(4):550-3. PubMed ID: 1057643
    [TBL] [Abstract][Full Text] [Related]  

  • 156. Decreased expression of the Fas ligand on peripheral blood mononuclear cells and undetectable levels of soluble Fas ligand in the serum of patients with aplastic anemia and myelodysplastic syndrome.
    Shinohara K; Takahahi T; Nawata R; Oeda E
    Am J Hematol; 1999 Oct; 62(2):124-5. PubMed ID: 10509009
    [No Abstract]   [Full Text] [Related]  

  • 157. [Hemorrhagic and neurological complications in aplastic anemia patients].
    Bessmel'tsev SS; Khorshev SK; Abdulkadyrov KM; Shilova ER
    Ter Arkh; 1996; 68(2):56-9. PubMed ID: 8771661
    [TBL] [Abstract][Full Text] [Related]  

  • 158. [Paraproteinemia in differential diagnosis of hypoplastic anemia and acute leukemia].
    Soloveĭ DIa; Iavorkovskiĭ LI; Press BO; Vigant VIa; Iavorkovskaia EK
    Probl Gematol Pereliv Krovi; 1976 Jul; 21(7):49-53. PubMed ID: 1025561
    [No Abstract]   [Full Text] [Related]  

  • 159. [Histopathology of bone marrow in "refractory anemia". A study of 77 cases using semi-thin sections (author's transl)].
    Kermarec J; Canioni D
    Ann Chir; 1981; 29(3):161-71. PubMed ID: 7259321
    [No Abstract]   [Full Text] [Related]  

  • 160. [Successful treatment with deferoxamine in a case of refractory anemia].
    Tomoyasu S; Kawakami K; Onizuka T; Ishiyama T; Tsuruoka N
    Rinsho Ketsueki; 1993 Jun; 34(6):743-7. PubMed ID: 8366578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.